| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/THX.2009.128082 |
| P8608 | Fatcat ID | release_wyeua7ry4ngddjget3ekn5ud6i |
| P698 | PubMed publication ID | 20871122 |
| P5875 | ResearchGate publication ID | 46427604 |
| P50 | author | Laura C Rodrigues | Q50848927 |
| Jack E Gibson | Q56912300 | ||
| P2093 | author name string | Christopher J Smith | |
| Richard B Hubbard | |||
| Johanna R Feary | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| chronic obstructive pulmonary disease | Q199804 | ||
| comorbidity | Q1414874 | ||
| P304 | page(s) | 956-962 | |
| P577 | publication date | 2010-09-25 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care | |
| P478 | volume | 65 |
| Q40067256 | A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study |
| Q35999260 | A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD. |
| Q37644823 | Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links |
| Q48162076 | Advances in chronic obstructive pulmonary disease |
| Q37616961 | Bronchiectasis and the risk of cardiovascular disease: a population-based study |
| Q54051804 | CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. |
| Q26746530 | COPD and stroke: are systemic inflammation and oxidative stress the missing links? |
| Q43702981 | CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes |
| Q38705614 | Cardiac effects of current treatments of chronic obstructive pulmonary disease |
| Q38008477 | Cardiorespiratory fitness after stroke: a systematic review |
| Q50051202 | Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco. |
| Q36836417 | Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS) |
| Q38833618 | Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk |
| Q36239420 | Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study. |
| Q38604642 | Characteristics of COPD Patients Using United States Emergency Care or Hospitalization |
| Q92290085 | Characteristics of factors for decreased lung function in elderly patients with type 2 diabetes |
| Q36558243 | Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities |
| Q39268464 | Chronic Obstructive Pulmonary Disease and the Risk of Stroke |
| Q41297968 | Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study |
| Q27027955 | Chronic obstructive pulmonary disease |
| Q55381292 | Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes. |
| Q38111151 | Chronic obstructive pulmonary disease and cardiovascular disease |
| Q38169870 | Chronic obstructive pulmonary disease and comorbidities |
| Q34967791 | Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey |
| Q36402823 | Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony |
| Q38342003 | Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management |
| Q37516810 | Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol. |
| Q36308003 | Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). |
| Q35636099 | Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010. |
| Q37988881 | Chronic obstructive pulmonary disease: consequences beyond the lung. |
| Q28646419 | Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease |
| Q50724186 | Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. |
| Q34500895 | Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. |
| Q92754551 | Common Comorbidities of Stroke in the Canadian Population |
| Q26799659 | Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management |
| Q39101061 | Comorbidities and Subgroups of Patients Surviving Severe Acute Hypercapnic Respiratory Failure in the Intensive Care Unit. |
| Q36575269 | Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations |
| Q35087187 | Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans |
| Q34564347 | Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? |
| Q34549923 | Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study |
| Q36552979 | Comparison of frequency of insulin resistance in patients with chronic obstructive pulmonary disease with normal controls. |
| Q37930206 | Controversies in treatment of chronic obstructive pulmonary disease |
| Q43685098 | Correlation between lower gastrointestinal tract symptoms and quality of life in patients with stable chronic obstructive pulmonary disease |
| Q28395087 | Cross-sectional and prospective study of the association between lung function and prediabetes |
| Q47651592 | Defining the relationship between COPD and CVD: what are the implications for clinical practice? |
| Q34287954 | Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study |
| Q50698868 | Diabetes mellitus among outpatients with COPD attending a university hospital. |
| Q33565593 | Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality. |
| Q41432972 | Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies |
| Q28660388 | Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records |
| Q30569184 | Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study. |
| Q34134841 | Epidemiology and clinical impact of major comorbidities in patients with COPD. |
| Q54975915 | Excess risk of major vascular diseases associated with airflow obstruction: a 9-year prospective study of 0.5 million Chinese adults. |
| Q35939395 | Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice |
| Q37940008 | Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. |
| Q37673443 | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
| Q35986343 | Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study |
| Q61453242 | High Prevalence of Diabetes Mellitus in a Cohort of Patients with Chronic Obstructive Pulmonary Disease in Trinidad, West Indies |
| Q58561676 | High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia |
| Q38629795 | Human cerebral blood flow control during hypoxia: focus on chronic pulmonary obstructive disease (COPD) and obstructive sleep apnea (OSA). |
| Q36797618 | INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units |
| Q58589460 | Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease |
| Q35767140 | Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke--a retrospective analysis |
| Q34787441 | Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients |
| Q35695265 | Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. |
| Q37669183 | Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population |
| Q59811986 | Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study |
| Q42688095 | Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD |
| Q97569891 | In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity |
| Q40854299 | Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease |
| Q35897669 | Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer |
| Q27026426 | Influence of diet and obesity on COPD development and outcomes |
| Q35687073 | Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach |
| Q33649907 | Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors? |
| Q35222216 | Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations |
| Q37964807 | Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice |
| Q33565787 | Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease |
| Q90608230 | Lung Function in Young Adults and Risk of Cardiovascular Events Over 29 Years: The CARDIA Study |
| Q27005858 | Managing comorbidities in COPD |
| Q47098529 | Measuring cardiovascular risk in COPD; child's play or MENSA? |
| Q90200040 | MicroRNA-494 Inhibits the LRG1 Expression to Induce Proliferation and Migration of VECs in Rats following Myocardial Infarction |
| Q62111191 | Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease |
| Q50554528 | Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. |
| Q36391975 | NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study |
| Q21146673 | Network medicine analysis of COPD multimorbidities |
| Q37947846 | Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease |
| Q36557662 | No association between exacerbation frequency and stroke in patients with COPD. |
| Q51312447 | Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study. |
| Q87585505 | Nontuberculosis mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study |
| Q42201896 | Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease. |
| Q34609913 | One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. |
| Q60626929 | Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients |
| Q38155607 | Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers. |
| Q39430464 | Physical activity in patients with COPD: the impact of comorbidities. |
| Q35662631 | Presentation of respiratory symptoms prior to diagnosis in general practice: a case-control study examining free text and morbidity codes |
| Q37103925 | Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study |
| Q46547960 | Prevalence of chronic obstructive pulmonary disease and risk factors in São Paulo, Brazil, 2008-2009. |
| Q40557048 | Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease |
| Q57312139 | Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan |
| Q35658302 | Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease. |
| Q30927990 | Quantification of diabetes comorbidity risks across life using nation-wide big claims data |
| Q43500670 | Quantifying health services use for chronic obstructive pulmonary disease |
| Q28066773 | Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD? |
| Q93027457 | Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review |
| Q39627275 | Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD. |
| Q38553747 | Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q26781406 | Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis |
| Q52659739 | Risk of stroke in patients with dengue fever: a population-based cohort study. |
| Q43248881 | Roflumilast in COPD: a Brazilian perspective |
| Q41375399 | Roflumilast: a green signal is yet to come |
| Q26770501 | Roflumilast: a review of its use in the treatment of COPD |
| Q35268351 | Safety of indacaterol in the treatment of patients with COPD. |
| Q35244561 | Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India |
| Q59802362 | Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review |
| Q92552859 | Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD) |
| Q38345525 | Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease |
| Q53069143 | Stroke risk among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. |
| Q38006928 | Systemic inflammation and comorbidities in chronic obstructive pulmonary disease |
| Q38056532 | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease |
| Q36365175 | Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD. |
| Q55475810 | The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk. |
| Q39404790 | The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with COPD. |
| Q41130169 | The association between glucose levels and hospital outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease |
| Q48525384 | The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities |
| Q92180440 | The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort |
| Q34478144 | The link between chronic periodontitis and COPD: a common role for the neutrophil? |
| Q22305858 | The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease |
| Q38896877 | Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease. |
| Q36825056 | Understanding perception of chronic obstructive pulmonary disease among general practitioners, physicians, and pulmonologists in India: Results from a face-to-face survey. |
| Q57815909 | Validation of lung density indices by cardiac CT for quantification of lung emphysema |
| Q50795103 | [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis]. |
| Q100158606 | β-blockers bind ADRB1,2,3 |
Search more.